leadf
logo-loader
viewBoadicea Resources

Boadicea Resources granted Giles South exploration licence in Fraser Range

The licence is for the E28/2952 tenement and has a total area of 14 blocks covering around 42 square kilometres.

Boadicea Resources - Boadicea Resources granted Giles South tenement exploration licence in the Fraser Range
Giles South is about 45 kilometres north of the Mawson nickel sulphide discovery of Legend Mining

Boadicea Resources Ltd (ASX:BOA) has been granted an exploration licence for the Giles South tenement in the Fraser Range in Western Australia, one of the hottest exploration addresses in Australia.

The nickel, copper and gold miner said the licence was for the E28/2952 tenement and had a total area of 14 blocks covering around 42 square kilometres.

E28/2952 forms part of the package of nine tenements subject to Boadicea's conditional sale agreement with IGO Newsearch Pty Ltd, a wholly-owned subsidiary of IGO Ltd (ASX:IGO).

North of Legend Mawson discovery

The licence E28/2952 was granted on September 9, 2020, for a period of five years and has an expenditure commitment of $20,000 in the first year.

Giles South is about 45 kilometres north of the Mawson nickel sulphide discovery by Legend Mining Limited (ASX:LEG).

Enviable position in Fraser Range

Boadicea has established a strong Fraser Range foothold in recent years and is confident of the prospectivity for nickel sulphides.

Under the terms of the agreement with IGO Newsearch, Boadicea Resources is free carried for all costs and exploration commitments.

This transformational agreement will see IGO acquire nine BOA Fraser Range licences, including ballot wins.

The Fraser Range has attracted global attention due to the three deposits delineated in the region – IGO’s operating Nova mine, Legend Mining’s Mawson discovery and Creasy Group’s Silver Knight.

Quick facts: Boadicea Resources

Price: 0.245 AUD

ASX:BOA
Market: ASX
Market Cap: $15.15 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Boadicea Resources named herein, including the promotion by the Company of Boadicea Resources in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

OptiBiotix Health 'proves commercial model' in 2020, focus now on 'next...

OptiBiotix Health PLC's (LON:OPTI) Stephen O'Hara explains how the company managed to prove their commercial model with a solid foundation to begin 2021 in a strong position. He sets out the agenda for 2021 which is to 'focus on the next generation of products'. The company's key products,...

21 hours, 17 minutes ago

2 min read